Pediatr. praxi. 2012;13(2):80-82

Biological treatment of juvenile idiopathic arthritis

MUDr.Dana Němcová, doc.MUDr.Pavla Doležalová, CSc.
Klinika dětského a dorostového lékařství 1. LF UK a VFN Praha

Juvenile idiopathic arthritis (JIA) is a systemic autoimmune inflammatory disease leading to progressive changes in the joints with

a reduction of their mobility and limiting daily activities. They are listed indications and procedures for the deployment of biological

treatment, other treatment options and recommendations severe forms of JIA.

Keywords: juvenile idiopathic arthritis, biological medicines, advice

Published: April 25, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Němcová D, Doležalová P. Biological treatment of juvenile idiopathic arthritis. Pediatr. praxi. 2012;13(2):80-82.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Petty RE, Southwood TR, Baum J, et al. Revision of the proposed classification criteria for juvenilie idiopathic arthritis: Durban, 1997. J Rheumatol. 1998; 25: 1991-1994. Go to PubMed...
    2. Petty RE, Southwood TR, Manners P, et al. International league of associations for rheumatology classification of juvenilie idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004; 31: 390-392. Go to PubMed...
    3. Woo P, Wederburn LR. Juvenilie chronic arthritis. Lancet 1998; 351: 969-973. Go to original source...
    4. Beukelmann T, Patkar NM, Saag KG, et al. American College of Rheumatology Recommendations for the Treatment of Juvenilie Idiopathic Arthritis: Initiation and Safety Monitoring of Therapeutic\agents for the Treatment of Arthritis and Systemic Features. Arthritis Care & Reasearch. 2011; 63 (4): 465-482 DOI. 10.1002/acr.20460. Go to original source... Go to PubMed...
    5. Lovell DJ, Giannini EH, Reiff A, et al. Long-term efficacy and safety of etanercept in children with polyarticular - course juvenilie rheumatoid arthritis: interim results from ongoing multicenter, open-label, extended - treatment trial. Arthritis Rheum 2003; 48: 218-226. Go to original source... Go to PubMed...
    6. Lovell DJ, Ruperto N, Goodman S, et al. A Randomized, Placebo-Controlled Trial of Adalimumab with or without Methotrexate in Children with Polyarticular Juvenilie Rheumatoid Arthritis. N Engl J Med 2007.
    7. Yokota S, Miyamae T, Umagowa T, et al. Therapeutic efficasy of Humanized recombinant anti-interleukin-6 receptor antipody in children with systemic - onsent juvenilie idiopathic arthritis. Arthritis Thein 2005; 52: 818-825. Go to original source... Go to PubMed...

    Return to the content


    Pediatrics for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.